(Q41526311)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Florenzo Iannone

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Luca Cantarini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Giovanni Lapadula

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Michele Barone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Maria Teresa Viggiani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Alfonso W Avolio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Alfredo Di Leo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Antonella Notarnicola

2

object named as

Antonella Notarnicola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

6

Michele Covelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Francesco Sebastiani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

24 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

40-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

28 February 2020

cites work

1 reference

Assessing the safety of biologic agents in patients with rheumatoid arthritis

21 January 2018

1 reference

The role of tocilizumab in the management of rheumatoid arthritis

21 January 2018

1 reference

The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.

21 January 2018

1 reference

Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy

21 January 2018

1 reference

Prophylaxis and treatment of hepatitis B in immunocompromised patients

21 January 2018

1 reference

Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease

21 January 2018

1 reference

Management of hepatitis B: summary of a clinical research workshop

21 January 2018

1 reference

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

21 January 2018

1 reference

Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management

21 January 2018

1 reference

Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy

21 January 2018

1 reference

Statements from the Taormina expert meeting on occult hepatitis B virus infection

21 January 2018

1 reference

21 January 2018

1 reference

Occult hepatitis B virus in liver tissue of individuals without hepatic disease

21 January 2018

1 reference

Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies

21 January 2018

1 reference

Chronic hepatitis B: update 2009

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.

21 January 2018

1 reference

Safety of tumor necrosis factor alpha blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases

21 January 2018

1 reference

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

21 January 2018

1 reference

Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient

21 January 2018

1 reference

Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature

21 January 2018

1 reference

Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients

21 January 2018

1 reference

Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs

21 January 2018

1 reference

Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts

21 January 2018

1 reference

Possible reactivation of potential hepatitis B virus occult infection by tumor necrosis factor-alpha blocker in the treatment of rheumatic diseases.

21 January 2018

1 reference

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports

21 January 2018

1 reference

Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.

21 January 2018

1 reference

The clinical implications of hepatitis B virus genotype: Recent advances.

21 January 2018

1 reference

Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy

21 January 2018

1 reference

Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).

21 January 2018

1 reference

Patients with hematological malignancies and serological signs of prior resolved hepatitis B.

21 January 2018

1 reference

Occult hepatitis B virus infection

21 January 2018

1 reference

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.27716

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25613809%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference